HOME >> BIOLOGY >> NEWS
'New and better drugs for tuberculosis' goal of UH professor

HOUSTON, Aug. 13, 2004 In Kurt Krause's laboratory, what starts off as a mere molecule may soon become a potential drug to treat tuberculosis.

Krause, an associate professor of biology and biochemistry at the University of Houston, has been invited to discuss this research at The Protein Society's 18th Annual Symposium "Protein Structure, Function and Disease" Aug. 14-18, in San Diego, Calif.

"Alanine racemase is a protein from tuberculosis that is a target for drug design," Krause said. "We are trying to make a small molecule that will specifically inhibit this enzyme. A molecule of this type would be a potential antibiotic to treat TB."

Sponsored by the National Institutes of Health National Institute of Allergy and Infectious Diseases, this research is the result of a collaborative research project that includes Krause and three others. Also from the University of Houston is James Briggs, assistant professor of biology and biochemistry at UH, with former UH professors Mike Benedik, now of Texas A&M University, and Hal Kohn, now of the University of North Carolina.

As part of session nine, "Biochemistry and Structural Biology for Understanding and Combating Tuberculosis," Krause's talk "Alanine Racemase As a Template for TB Drug Design" will begin at 11:55 a.m., Tuesday, Aug. 17, in the Marina Ballroom FG at the San Diego Marriott Hotel & Marina, with the floor opening at 12:20 p.m. for group discussion.

"Ultimately, our team's goal is to develop new and better drugs for TB," Krause said. "I'm honored to be representing our work at this symposium as a result of the recommendations of fellow researchers in the scientific community who have knowledge of our research."

The Protein Society symposium will take the traditional focus on protein structure and function in new directions. A significant portion of the talks at this year's event will provide a protein science perspective on several major in
'"/>

Contact: Lisa Merkl
lkmerkl@uh.edu
713-743-8192
University of Houston
13-Aug-2004


Page: 1 2

Related biology news :

1. Lycopene slows human prostate tumour growth in mice and combined with vitamin E is even better
2. Microbes eat their way to better concrete
3. Computer database being developed at Temple will allow for better inventory of chemicals
4. Ants protect plants better when jacked up on nectar
5. The blind really do hear better
6. Microarrays, key genome expression trackers, work better when probes are sequence-verified
7. Researchers develop better understanding of immune response to viral infection
8. Crack babies do better when placed with non-family caregivers
9. A better way to copy DNA
10. Gene profiles could improve acute leukemia diagnosis and lead to better treatments
11. Access to DNA secrets yields better understanding of genes, possible tool for disease diagnosis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/14/2019)... , ... December 12, 2019 , ... ... that protect or enhance crop yields, has appointed Jean Pougnier as chief business ... establish relationships with go-to-market partners and influencers that will position the company for ...
(Date:12/2/2019)... ... December 01, 2019 , ... ... tools, technologies, and techniques to hit the life-science landscape. For more than a ... speeding work in laboratories and facilitating biological discovery. This year’s crop of entries ...
(Date:11/22/2019)... BUFFALO, N.Y. (PRWEB) , ... November 21, 2019 ... ... immunotherapy developed at Roswell Park Comprehensive Cancer Center have announced a major step ... and Michael Ciesielski, PhD, have announced that the company, spun off from Roswell ...
Breaking Biology News(10 mins):
(Date:12/18/2019)... ... December 18, 2019 , ... Tune in to CNBC on Saturday, December 28th ... local listings for more information on this program. , With a look at ... simplify complex system to increase the efficiency, safety and effectiveness of equipment, systems, and ...
(Date:12/6/2019)... ... December 06, 2019 , ... Southern ... for its latest CAPERE® Thrombectomy System for peripheral vascular, deep vein thrombosis ... benefits for first-in-line treatment for nonsurgical removal of soft emboli and thrombi ...
(Date:12/4/2019)... ... December 03, 2019 , ... Absolute Antibody Ltd. , ... with the Recombinant Antibody Network (RAN), a consortium of three expert centers at ... a common goal to generate recombinant antibodies at a proteome-wide scale. Under the ...
(Date:12/4/2019)... ... December 03, 2019 , ... A new study released ... can reduce and even reverse fibrosis (scar tissue) buildup – also improves the range ... School of Medicine, was conducted on mice. , The tumor-destroying capabilities of radiation ...
Breaking Biology Technology:
Cached News: